Literature DB >> 20816854

IL-2 induces conformational changes in its preassembled receptor core, which then migrates in lipid raft and binds to the cytoskeleton meshwork.

Anne-Hélène Pillet1, Vincent Lavergne, Virginie Pasquier, Franck Gesbert, Jacques Thèze, Thierry Rose.   

Abstract

While interleukin (IL)-2 clearly initiates the sequential assembly of its soluble receptor fragments (sIL-2R) in vitro (with sIL-2Rα first, sIL-2Rβ second, and sγc last), the assembly mechanism of full-length subunits (IL-2R) at the surface of living lymphocytes remains to be elucidated. Here we demonstrate by fluorescence cross-correlated spectroscopy that native IL-2Rβ and γc assemble spontaneously at the surface of living human leukemia T cells (Kit-225 cell line) in the absence of IL-2 and with 1:1 stoichiometry. The dissociation constant of the membrane-embedded IL-2Rβ/γc complex is measured in situ. Förster fluorescence resonance energy transfer analyzed by confocal microscopy of transfected COS-7 cells between combination pairs of various-length receptor chain constructions, using green fluorescent protein derivatives as cytoplasmic carboxy-terminal extensions, showed that IL-2Rβ:ECFP and γc:EYFP bind each other through their extracellular domains, and that IL-2 binding brings their transmembrane domains 30 Å closer together. These observations demonstrate that IL-2Rβ/γc heterodimers are preformed and that their cytoplasmic domains, carrying Janus kinase (Jak) 1 and Jak3, are pulled and tethered together on cytokine binding, triggering signaling transduction. IL-2 binding stabilizes IL-2/IL-2R complexes in membrane nanodomains that promote Jak1/Jak3 phosphorylation. The complexes then interact with the cytoskeleton, which slows receptor diffusion (as measured by fluorescence cross-correlated spectroscopy) and promotes STAT (signal transducer and activator of transcription) 5 phosphorylation. Separation of IL-2-activated receptors from Triton-lysed cells in detergent-resistant membrane nanodomains by ultracentrifugation on a sucrose gradient confirmed their presence in lipid rafts. The release of the IL-2-activated receptor from cytochalasin-treated cells and the IL-2-induced recruitment of actin and tubulin, analyzed by immunoprecipitation, confirmed that the activated receptor interacts with the cytoskeleton. Although IL-2Rα (the third chain that gives the IL-2Rβ/γc receptor core its high affinity for IL-2) is highly expressed at the cell surface and mainly clustered in membrane microdomains at the surface of Kit-225 cells, the few free IL-2Rα present bind last to the IL-2/IL-2Rβ/γc complex and lock IL-2 to its binding site for prolonged action, promoting signal amplification.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20816854     DOI: 10.1016/j.jmb.2010.08.056

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  23 in total

1.  Structural reorganization of the interleukin-7 signaling complex.

Authors:  Craig A McElroy; Paul J Holland; Peng Zhao; Jae-Min Lim; Lance Wells; Edward Eisenstein; Scott T R Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  MHC I Expression Regulates Co-clustering and Mobility of Interleukin-2 and -15 Receptors in T Cells.

Authors:  Gábor Mocsár; Julianna Volkó; Daniel Rönnlund; Jerker Widengren; Péter Nagy; János Szöllősi; Katalin Tóth; Carolyn K Goldman; Sándor Damjanovich; Thomas A Waldmann; Andrea Bodnár; György Vámosi
Journal:  Biophys J       Date:  2016-07-12       Impact factor: 4.033

Review 3.  The common γ-chain cytokine receptor: tricks-and-treats for T cells.

Authors:  Adam T Waickman; Joo-Young Park; Jung-Hyun Park
Journal:  Cell Mol Life Sci       Date:  2015-10-14       Impact factor: 9.261

4.  Cucurbitacin I inhibits STAT3, but enhances STAT1 signaling in human cancer cells in vitro through disrupting actin filaments.

Authors:  Hui Guo; Shan Kuang; Qiao-Ling Song; Man Liu; Xiao-Xiao Sun; Qiang Yu
Journal:  Acta Pharmacol Sin       Date:  2017-11-09       Impact factor: 6.150

5.  IL-2 receptors preassemble and signal in the ER/Golgi causing resistance to antiproliferative anti-IL-2Rα therapies.

Authors:  Julianna Volkó; Ádám Kenesei; Meili Zhang; Péter Várnai; Gábor Mocsár; Michael N Petrus; Károly Jambrovics; Zoltán Balajthy; Gabriele Müller; Andrea Bodnár; Katalin Tóth; Thomas A Waldmann; György Vámosi
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-30       Impact factor: 11.205

6.  Annexin A6 regulates interleukin-2-mediated T-cell proliferation.

Authors:  Rhea Cornely; Abigail H Pollock; Carles Rentero; Sarah E Norris; Anna Alvarez-Guaita; Thomas Grewal; Todd Mitchell; Carlos Enrich; Stephen E Moss; Robert G Parton; Jérémie Rossy; Katharina Gaus
Journal:  Immunol Cell Biol       Date:  2016-02-08       Impact factor: 5.126

7.  Membrane microdomains and cytoskeleton organization shape and regulate the IL-7 receptor signalosome in human CD4 T-cells.

Authors:  Blanche Tamarit; Florence Bugault; Anne-Hélène Pillet; Vincent Lavergne; Pascal Bochet; Nathalie Garin; Ulf Schwarz; Jacques Thèze; Thierry Rose
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

8.  Membrane Potential Distinctly Modulates Mobility and Signaling of IL-2 and IL-15 Receptors in T Cells.

Authors:  Éva Nagy; Gábor Mocsár; Veronika Sebestyén; Julianna Volkó; Ferenc Papp; Katalin Tóth; Sándor Damjanovich; György Panyi; Thomas A Waldmann; Andrea Bodnár; György Vámosi
Journal:  Biophys J       Date:  2018-05-10       Impact factor: 4.033

9.  Cell-to-cell variability analysis dissects the plasticity of signaling of common γ chain cytokines in T cells.

Authors:  Jesse W Cotari; Guillaume Voisinne; Orly Even Dar; Volkan Karabacak; Grégoire Altan-Bonnet
Journal:  Sci Signal       Date:  2013-03-12       Impact factor: 8.192

Review 10.  Structural insights into the common γ-chain family of cytokines and receptors from the interleukin-7 pathway.

Authors:  Scott T R Walsh
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.